Literature DB >> 3734434

Immunoglobulin G, A and M response to influenza vaccination in different age groups: effects of priming and boosting.

W E Beyer, J T Van der Logt, R van Beek, N Masurel.   

Abstract

Fifty volunteers, treated with an inactivated trivalent influenza vaccine containing A/Bangkok/1/79 (H3N2), A/Brazil/11/78 (H1N1) and B/Singapore/222/79 virus, were subdivided according to the estimated first exposure to influenza in their lifetime (priming) and the presence of antibodies against the vaccine components in the pre-vaccination sera. The isotypic antibody response (IgG, IgA, IgM) was determined by means of an antibody capture haemadsorption immunosorbent technique. For all three vaccine components, previously seropositive subjects produced antibodies of the IgG- and IgA-class more frequently than previously seronegative persons. Subjects primed to one of the influenza A subtypes showed more IgG and IgA responses in comparison with those unprimed (prime-effect). In contrast, IgM antibodies occurred in only 19 and 11% of primed, but in 59 and 54% of unprimed subjects, for A (H3N2) and A (H1N1), respectively. The incidence of IgM titre rises was not influenced by the prevaccination state. However, the mean magnitude of anti-A (H1N1)-IgM titre rises was greater in those previously seronegative. The concepts of primary and reinfection and of 'original antigenic sin' are discussed, and it is suggested that age and, if possible, serological state prior to antigen-exposure should be taken into account when studying isotypic antibody responses after influenza infection or vaccination.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3734434      PMCID: PMC2129686          DOI: 10.1017/s0022172400066316

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  22 in total

1.  A METHOD FOR INCREASING THE SENSITIVITY OF THE HEMAGGLUTINATION-INHIBITION TEST WITH EQUINE INFLUENZA VIRUS.

Authors:  B S BERLIN; J L MCQUEEN; E MINUSE; F M DAVENPORT
Journal:  Virology       Date:  1963-12       Impact factor: 3.616

Review 2.  Vaccination against influenza A.

Authors:  D A Tyrrell; J W Smith
Journal:  Br Med Bull       Date:  1979-01       Impact factor: 4.291

3.  Recycling of Asian and Hong Kong influenza A virus hemagglutinins in man.

Authors:  N Masurel; W M Marine
Journal:  Am J Epidemiol       Date:  1973-01       Impact factor: 4.897

4.  Antibody response obtained by vaccination with the influenza A-Equi 2 virus in man.

Authors:  N Masurel
Journal:  Nature       Date:  1968-04-06       Impact factor: 49.962

5.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation.

Authors:  D C Wiley; I A Wilson; J J Skehel
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

6.  Antibody response against current H1N1 influenza virus after vaccination with last season's trivanent vaccine.

Authors:  N Masurel; F E André
Journal:  Lancet       Date:  1978-01-21       Impact factor: 79.321

7.  IgM and IgG antibody responses following immunization of children and adults with influenza A/NJ/76 vaccines.

Authors:  K M Boyer; J D Cherry; G R Noble
Journal:  Dev Biol Stand       Date:  1977 Jun 1-3

8.  Single-radial-hemolysis: a new method for the assay of antibody to influenza haemagglutinin. Applications for diagnosis and seroepidemiologic surveillance of influenza.

Authors:  G C Schild; M S Pereira; P Chakraverty
Journal:  Bull World Health Organ       Date:  1975       Impact factor: 9.408

9.  Antibody response to immunization with influenza A/USSR/77 (H1N1) virus in young individuals primed or unprimed for A/New Jersey/76 (H1N1) virus.

Authors:  N Masurel; P Ophof; P de Jong
Journal:  J Hyg (Lond)       Date:  1981-10

10.  Hemadsorption immunosorbent technique for determination of rubella immunoglobulin M antibody.

Authors:  J T van der Logt; A M van Loon; J van der Veen
Journal:  J Clin Microbiol       Date:  1981-03       Impact factor: 5.948

View more
  7 in total

1.  Influenza subtype-specific IgA, IgM and IgG responses in patients on hemodialysis after influenza vaccination.

Authors:  P Rautenberg; I Teifke; T Schlegelberger; U Ullmann
Journal:  Infection       Date:  1988       Impact factor: 3.553

2.  Use of single radial haemolysis for assessing antibody response to influenza virus vaccines in animals.

Authors:  T L Smith; R Jennings; C W Potter
Journal:  Med Microbiol Immunol       Date:  1987       Impact factor: 3.402

3.  Effect of priming with H1N1 influenza viruses of variable antigenic distances on challenge with 2009 pandemic H1N1 virus.

Authors:  Christopher D O'Donnell; Amber Wright; Leatrice N Vogel; Chih-Jen Wei; Gary J Nabel; Kanta Subbarao
Journal:  J Virol       Date:  2012-06-06       Impact factor: 5.103

4.  Diagnosis of influenza A virus infections by detection of specific immunoglobulins M, A, and G in serum.

Authors:  T Vikerfors; G Lindegren; M Grandien; J van der Logt
Journal:  J Clin Microbiol       Date:  1989-03       Impact factor: 5.948

5.  Estimating the life course of influenza A(H3N2) antibody responses from cross-sectional data.

Authors:  Adam J Kucharski; Justin Lessler; Jonathan M Read; Huachen Zhu; Chao Qiang Jiang; Yi Guan; Derek A T Cummings; Steven Riley
Journal:  PLoS Biol       Date:  2015-03-03       Impact factor: 8.029

6.  The effects of fever on hormone ghrelins, immunoglobulins, and heat shock protein 70 expression after swine flu vaccinations.

Authors:  Suleyman Aydin; Tumer Guven; İbrahim Sahin; Aziz Aksoy; Yalçın Kendir; Mustafa N İlhan; Cihan Citil; Zekiye Catak; Cemal Ustun
Journal:  Endocrine       Date:  2012-04-04       Impact factor: 3.633

7.  Combined Exercise Training and l-Glutamine Supplementation Enhances Both Humoral and Cellular Immune Responses after Influenza Virus Vaccination in Elderly Subjects.

Authors:  Fernanda R Monteiro; Tamaris Roseira; Jonatas B Amaral; Vitória Paixão; Ewin B Almeida; Roberta Foster; Adriane Sperandio; Marcelo Rossi; Gislene R Amirato; Juliana S Apostólico; Carlos A F Santos; Eduardo S Felismino; Fabyano B Leal; Luciano M Thomazelli; Edison L Durigon; Danielle B L Oliveira; Rodolfo P Vieira; Juliana M B Santos; André L L Bachi
Journal:  Vaccines (Basel)       Date:  2020-11-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.